Research Article

The Impact of Beta Blockers on Survival in Heart Transplant Recipients: Insights from the Zabrze HTx Registry

Table 2

Laboratory findings.

Beta blockers: no
Mean ± SD
n = 242
Beta blockers: yes
Mean ± SD
n = 138

Creatinine (μmol/l)125.63 ± 48.63134.73 ± 64.660.597
Serum glucose (mmol/l)6.18 ± 2.456.31 ± 1.790.622
Hemoglobin A1c (%)5.50 ± 0.785.58 ± 0.870.489
White blood cells (103/μl)7.75 ± 3.767.31 ± 2.540.464
Red blood cells (106/μl)4.45 ± 0.684.63 ± 0.710.015
Platelets (103/μl)220.44 ± 76.77201.73 ± 62.390.024
Hemoglobin (mmol/l)8.12 ± 1.258.29 ± 1.220.132
Hematocrit0.39 ± 0.050.40 ± 0.050.022
C-reactive protein (mg/l)8.09 ± 20.4816.54 ± 33.810.131
Aspartate transaminase (IU/l)24.70 ± 14.6425.43 ± 18.110.693
Alanine aminotransferase (IU/l)21.88 ± 15.6723.01 ± 21.250.946
Total serum bilirubin (μmol/l)14.11 ± 10.8913.38 ± 7.420.403
Total protein (g/l)69.95 ± 6.6269.68 ± 5.940.520
Albumin (g/l)43.64 ± 4.6442.82 ± 4.370.114
Gamma-glutamyl transpeptidase (IU/l)88.02 ± 259.1977.94 ± 140.540.694
Alkaline phosphatase (IU/l)92.39 ± 48.75106.84 ± 165.610.603
Creatine phosphokinase (IU/l)124.01 ± 137.41126.94 ± 149.250.687
Uric acid (μmol/l)402.29 ± 114.00385.01 ± 99.020.337
Urea (mmol/l)8.47 ± 4.208.98 ± 5.060.760
Cystatin (mg/L)1.48 ± 0.691.62 ± 0.930.654
Cholesterol (mmol/l)4.25 ± 0.974.35 ± 1.340.892
Low-density lipoprotein (mmol/l)2.12 ± 0.842.21 ± 1.060.783
High-density lipoprotein (mmol/l)1.37 ± 0.431.30 ± 0.430.225
Activated partial thromboplastin time (s)34.01 ± 8.0533.00 ± 5.780.132
International normalized ratio1.08 ± 0.241.08 ± 0.270.467
Natrium (mmol/l)139.94 ± 3.15140.39 ± 2.710.264
Kalium (mmol/l)4.66 ± 0.484.63 ± 0.520.641
Magnesium (mmol/l)0.70 ± 0.130.72 ± 0.120.160
Fibrinogen (mg/dl)362.77 ± 109.28386.12 ± 134.600.177
Tacrolimus (ng/ml)9.40 ± 3.838.45 ± 3.630.037
Mycophenolate mofetil (μg/ml)2.27 ± 1.112.24 ± 1.220.407
Cyclosporin (ng/ml)141.01 ± 49.76110.60 ± 32.040.033

SD: standard deviation.